Zai Lab Limited ADR’s filing revealed that its Chief Financial Officer Chen Yajing unloaded Company’s shares for reported $15617.0 on Oct 02 ’25. In the deal valued at $34.25 per share,456 shares were sold. As a result of this transaction, Chen Yajing now holds 17,184 shares worth roughly $0.45 million.
Then, Chen Yajing bought 456 shares, generating $15,617 in total proceeds.
Before that, Smiley Joshua L bought 10,000 shares. Zai Lab Limited ADR shares valued at $289,100 were divested by the insider at a price of $28.91 per share. As a result of the transaction, Smiley Joshua L now holds 86,604 shares, worth roughly $2.28 million.
A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early March with a ‘”a Sector outperform”‘ rating. BofA Securities also remained covering ZLAB and has decreased its forecast on March 03, 2025 with a “Neutral” recommendation from previously “Buy” rating. Morgan Stanley started covering the stock on December 14, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Monday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock jump 0.08% to $26.34. Over the last five days, the stock has lost -8.35%. Zai Lab Limited ADR shares have fallen nearly -8.98% since the year began. Nevertheless, the stocks have risen 0.57% over the past one year. While a 52-week high of $44.34 was reached on 06/12/25, a 52-week low of $23.82 was recorded on 01/15/25.
Levels Of Support And Resistance For ZLAB Stock
The 24-hour chart illustrates a support level at 25.88, which if violated will result in even more drops to 25.41. On the upside, there is a resistance level at 26.75. A further resistance level may holdings at 27.15.
How much short interest is there in Zai Lab Limited ADR?
A steep rise in short interest was recorded in Zai Lab Limited ADR stocks on 2025-10-15, dropping by 70880.0 shares to a total of 4.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 4.88 million shares. There was a decline of -1.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 10, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
